atogepant

FDA Drug Profile

Drug Details

Generic Name
atogepant
Brand Names
N/A
Application Number
Sponsor
AbbVie Inc.
NDC Codes
3
Dosage Forms
TABLET
Routes
N/A
Active Ingredients
ATOGEPANT

Indications and Usage

1 INDICATIONS AND USAGE QULIPTA is indicated for the preventive treatment of migraine in adults. QULIPTA is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults. ( 1 )